Our studies are designed to identify the best ways to prevent, screen, detect, diagnose, and treat cancer and improve the quality of life of cancer survivors.
At #ASCO24@ASCO: Research led by @RoswellPark@KPDOR using data from the @kpnorcal Pathways Study finds a polygenic risk score has the potential to predict survival outcomes in patients with #breastcancer. Oral Abstract 10502; Sat. June 1. #bcsm
Story: https://t.co/5U4TKXFejU
It's official! Grateful to be an official @theNCI Cancer Screening Research Network site and to evaluate novel cancer screening technologies. Our first trial will test whether #MCDs can detect early cancers and save lives. @kpnorcal@KPDOR@Realcecum@MariaAnsariMD@srouillardmd
Among patients with #ColonCancer, results from this new study do not support home-based resistance training as an adjunct to chemotherapy specifically to improve planned treatment intensity.
https://t.co/uiRHgHcVx7
@OncoAlert@KPDOR@fitaftercancer#ExerciseOncology#GI24
Kudos to @KPDOR@kpnorcal@KPCancerRsrch research scientists Laurie Habel, @marilyn_kwan@LoriSakoda whose studies were selected as 2023 Research Highlights by @theNCI Epidemiology and Genomics Research Program!
See the full list of selected papers here: https://t.co/X39nDKIV1T
New results out today from the FORCE trial on home‐based resistance training on chemotherapy relative dose intensity and tolerability in colon cancer. In
@JournalCancer at https://t.co/IQAEKE6lor…
@KPDOR#CancerResearch#ColonCancer
Hot off the press @CCR_AACR: Female patients with advanced soft tissue sarcoma may have worse prognosis compared to male patients, according to the team of @KPCancerRsrch and Stanford sarcoma researchers. @KPDOR
Article link: https://t.co/Cgur6sZI81